JPRN-jRCT1080222854未知Unknown
Post-marketing surveillance of donepezil hydrochloride - Investigation of long term safety and efficacy of ARICEPT as well as its proper use information in patients with Dementia with Lewy bodies (DLB).
适应症
试验速览
- 阶段
- Unknown
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •ARICEPT-naive patients diagnosed as Dementia with Lewy bodies
排除标准
- •1)Patients with a history of donepezil hydrochloride product administration in the past.
- •2)Patients who have already been registered in this surveillance.
- •3)Patients with a history of hypersensitivity to any ingredients of ARICEPT or piperidine derivatives.
研究者
相似试验
未知
Unknown
Post-marketing surveillance of donepezil hydrochloride -Investigation of the clinical safety and effectiveness in patients with Alzheimer's DiseaseAlzheimer's DiseaseJPRN-jRCT1080221997Eisai Co., Ltd.1,000
未知
Unknown
Investigation of the safety and effectiveness of combination therapy of donepezil hydrochloride and memantine hydrochloride in patients with Alzheimer's DiseaseAlzheimer's DiseaseJPRN-jRCT1080222139Eisai Co., Ltd.5,000
未知
Unknown
Investigation of the factors that affect Aricept medication persistence rate and the safety and efficacy in patients with Alzheimer's Disease in clinical practiceAlzheimer's DiseaseJPRN-jRCT1080222138Eisai Co., Ltd.10,000
已完成
不适用
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's DiseaseAlzheimer's DiseaseNCT01251718Eisai Co., Ltd.894
已完成
不适用
Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's DiseaseAlzheimer's DeseaseNCT02162251Eisai Co., Ltd.3,482